Basic Information
ID: ALA5054101
Type: Binding
Description: Modulation of capsid assembly in HBV infected in human HepG2.2.15 cells assessed as fold shift in inhibition of viral DNA replication in presence of 40% normal human serum incubated for 3 days followed by replacement with fresh medium containing compound and measured after 3 days by QuantiGene assay
Organism: Hepatitis B virus
Cell type: HepG2.2.15
Activity Charts
Bioactivity
Activity Types for Assay ALA5054101
FC
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 430.42 | 2.23 | 2.23 |